BioXcel Therapeutics, Inc. (BTAI)
NASDAQ: BTAI · Real-Time Price · USD
0.326
+0.003 (0.96%)
At close: Jan 31, 2025, 4:00 PM
0.318
-0.008 (-2.45%)
After-hours: Jan 31, 2025, 6:17 PM EST
BioXcel Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2016 |
| Cash & Equivalents | 40.39 | 65.22 | 193.73 | 232.97 | 213.12 | 32.43 | Upgrade
|
| Cash & Short-Term Investments | 40.39 | 65.22 | 193.73 | 232.97 | 213.12 | 32.43 | Upgrade
|
| Cash Growth | -55.11% | -66.33% | -16.84% | 9.31% | 557.25% | -23.82% | Upgrade
|
| Accounts Receivable | 0 | 0.07 | 0.25 | - | - | - | Upgrade
|
| Receivables | 0 | 0.07 | 0.25 | - | - | - | Upgrade
|
| Inventory | 1.53 | 1.99 | 1.99 | - | - | - | Upgrade
|
| Prepaid Expenses | 4.48 | 2.78 | 3.07 | 2.89 | 2.96 | 1.68 | Upgrade
|
| Other Current Assets | 1.4 | 2.08 | 3.84 | 0.96 | 0.98 | - | Upgrade
|
| Total Current Assets | 47.79 | 72.14 | 202.87 | 236.81 | 217.07 | 34.11 | Upgrade
|
| Property, Plant & Equipment | 1.01 | 1.47 | 2.06 | 2.54 | 2.78 | 2.23 | Upgrade
|
| Other Long-Term Assets | 0.09 | 0.09 | 0.93 | 0.09 | 0.09 | 0.05 | Upgrade
|
| Total Assets | 48.89 | 73.7 | 205.85 | 239.44 | 219.94 | 36.39 | Upgrade
|
| Accounts Payable | 14.89 | 13.65 | 10.23 | 4.68 | 3.98 | 4.95 | Upgrade
|
| Accrued Expenses | 8.57 | 13.04 | 22.18 | 11.39 | 6.93 | 3.12 | Upgrade
|
| Current Portion of Leases | 0.37 | 0.35 | - | - | - | - | Upgrade
|
| Current Income Taxes Payable | 0.07 | 0.12 | 0.08 | 0.3 | 0.7 | - | Upgrade
|
| Other Current Liabilities | 1.66 | 0.11 | 0.4 | 0.29 | 0.24 | 0.4 | Upgrade
|
| Total Current Liabilities | 25.56 | 27.27 | 32.9 | 16.67 | 11.84 | 8.47 | Upgrade
|
| Long-Term Debt | 104.44 | 100.6 | 93.05 | - | - | - | Upgrade
|
| Long-Term Leases | 0.16 | 0.44 | 0.79 | 1.11 | 1.4 | 1.03 | Upgrade
|
| Other Long-Term Liabilities | 4.37 | 1.91 | 2.34 | - | - | - | Upgrade
|
| Total Liabilities | 134.53 | 130.21 | 129.08 | 17.77 | 13.24 | 9.5 | Upgrade
|
| Common Stock | 0.04 | 0.03 | 0.03 | 0.03 | 0.02 | 0.02 | Upgrade
|
| Additional Paid-In Capital | 553.66 | 534.06 | 488.29 | 467.43 | 345.53 | 83.57 | Upgrade
|
| Retained Earnings | -639.34 | -590.6 | -411.55 | -245.79 | -138.86 | -56.69 | Upgrade
|
| Shareholders' Equity | -85.63 | -56.51 | 76.78 | 221.67 | 206.7 | 26.9 | Upgrade
|
| Total Liabilities & Equity | 48.89 | 73.7 | 205.85 | 239.44 | 219.94 | 36.39 | Upgrade
|
| Total Debt | 104.97 | 101.38 | 93.84 | 1.11 | 1.4 | 1.03 | Upgrade
|
| Net Cash (Debt) | -64.58 | -36.16 | 99.89 | 231.86 | 211.72 | 31.4 | Upgrade
|
| Net Cash Growth | - | - | -56.92% | 9.51% | 574.34% | -26.24% | Upgrade
|
| Net Cash Per Share | -1.81 | -1.24 | 3.57 | 8.79 | 9.76 | 1.93 | Upgrade
|
| Filing Date Shares Outstanding | 42.75 | 30.58 | 29.01 | 27.98 | 24.57 | 20.18 | Upgrade
|
| Total Common Shares Outstanding | 42.46 | 29.93 | 28.15 | 27.98 | 24.42 | 18.09 | Upgrade
|
| Working Capital | 22.24 | 44.88 | 169.97 | 220.15 | 205.22 | 25.64 | Upgrade
|
| Book Value Per Share | -2.02 | -1.89 | 2.73 | 7.92 | 8.47 | 1.49 | Upgrade
|
| Tangible Book Value | -85.63 | -56.51 | 76.78 | 221.67 | 206.7 | 26.9 | Upgrade
|
| Tangible Book Value Per Share | -2.02 | -1.89 | 2.73 | 7.92 | 8.47 | 1.49 | Upgrade
|
| Machinery | 0.78 | 0.78 | 0.79 | 0.74 | 0.63 | 0.57 | Upgrade
|
| Construction In Progress | - | - | - | 0.02 | 0.36 | - | Upgrade
|
| Leasehold Improvements | 1.2 | 1.2 | 1.18 | 1.13 | 0.65 | 0.64 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.